Free and esterified carnitine in continuous ambulatory peritoneal dialysis patients

Kidney International

Volumn 49, Issue 1, 1996, Pages 158-162

  Constantin Teodosiu, Dumitru ^a   Kirby, David P J ^b   Short, Anthony H ^b   Burden, Richard P ^b   Morgan, Anthony G ^b   Greenhaff, Paul L ^b  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; CARNITINE DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0030042626     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.21     Document Type: Article

References (28)

1. FRITZ IB: Carnitine and its role in fatty acid metabolism. Adv Lipid Res 1:285-334, 1963
2. BIELER LL, EMAUS R, VALKNER K, FARRELL S: Possible functions of short-chain and medium-chain carnitine acyltransferases. Fed Proc 41:2858-2862, 1982
3. CONSTANTIN-TEODOSIU D, CARLIN JI, CEDERBLAD G, HARRIS RC, HULTMAN E: Acetyl group accumulation and pyruvate dehydrogenase activity in human muscle during incremental exercise. Acta Physiol Scand 143:367-372, 1991
4. BATTISTELLA PA, ANGELINI C, VERGANI L, BERTOLI M, LORENZI S: Carniline deficiency induced during haemodialyis, Lancet 1:934, 1978
5. BÖHMER T, BERGREM H, EIKLID K: Carnitine deficiency induced during intermittent haemodialysis for renal failure. Lancet 1:126-128, 1978
6. MOORTHY AV, ROSENBLUM M, RAJARAM R, SHUG AL: A comparison of plasma and muscle carnitine levels in patients on peritoneal or hemodialysis for chronic renal failure. Am J Nephrol 3:205-208, 1983
7. WANNER C, FÖRSTNER-WANNER S, RÖSSLE C, FÜRST P, SCHOLLMEYER P, HÖRI WH: Carnitine metabolism in patients with chronic renal failure: Effect of L-carnitine. Kidney Int 32(Suppl 22):S132-S135, 1987
8. LESCHKE M, RUMPF KW, EISENHAUER T, FUCUS C, BECKER K, KÖTHE U. SCHELLER F: Ouantitative assessment of carnitine loss during hemodialysis and hemofiltration. Kidney Int 24(Suppl 16):S143-S146, 1983
9. FAGHER B, CEDERBLAD G, ERIKSSON M, MONTI M, MORITZ U. NILSSON-EHLE P, THYSSELL H: L-carnitine and haemodialysis: Double blind study on muscle function and metabolism and peripheral function. Scand J Clin Lab Invest 45:169-178, 1985
10. RICANATI ES, HOPPEL CL: Hemodialysis (HD) in chronic renal failure (CRF) does not produce carnitine (C) depletion, (abstract) Kidney Int 27:170, 1985
11. ALBRIGHT RK, KRAM BW, WHITE RP: Carnitine status of continuos ambulatory peritoneal dialysis puticnls. Lancet 2:218-219, 1982
12. AMAIR P, GREGORIADIS A, RODELA, OGILVIE R. KHANNA R, BRANDES L, RONCARI DAK, OREOPOULOS DG: Serum carnitine in patients on continuous ambulatory periloneal dialysis (CAPD). Perit Dial Bull 2:11-12, 1982
13. MOORTH AV, SHUG AL: Elevated plasma carnitine levels on CAPD. Peril Dial Bull 5:175-179, 1985
14. BUONCRISTIANI U, DI PAULO N, CAROBI C, COZZARI M, QUINTALIANI G. BRACAGLIA R: Carnitine depletion with CAPD, in Advances in Peritoneal Dialysis, edited by GAHI. GM, KESSEL M, NOLPH KD. Amsterdam, Excerpta Medica, 1981, pp 441-445
15. DI MACRO S, SCOTP C, PENN AS, ROWLAND LP: Serum carnitine. Arch Neurol 28:186-190, 1973
16. CEDERBALD G: Plasma earnitine anil body composition. Clin Chim Acta 67:207-212, 1976
17. CEDERBALD G, LINDSTEDT S: A method for the determination of carnitine in the picomole range. Clin Chim Acta 37:235-243, 1972
18. CEDERBLAD G, CARLIN JI, CONSTANTIN-TEODOSIU D, HARPER P, HULTMAN B: Radioisotopic assays of CoASH and carnitine and their acetylated forms in human skeletal muscle. Anal Biochem 185:274-278, 1990
19. BÖHMER T, RYDING A, SOLBERG HE: Carniline levels in human serum in health and disease. Clin Chim Actd 57:55-61, 1974
20. GENUTH SM, HOPPEL CL: Plasma and urine carnitine in diabetic kelosis. Diabetes 28:1083-1087, 1979
21. HOPPEL CL, GENUTH SM: Carnitine metabolism in normal-weight and obese human subjects during fasting. Am J Physiol 23S:E409-E415, 1980
22. CARLIN JI, REDDAS WR, SANJAK M, HODACM R: Carnitine metabolism during prolonged exercise and reeovery in humans. J Appl Physiol 61:1275-1278. 1986
23. LETTFR TO EDITOR: Role of L-carnitine in treating renal dialysis patients. Dial Transplant 23:177-181, 1994
24. WINTER SC, SZARO-ACZEL S, CURRY CJR, HUCTHINSON HT, HOGUE R, SHUG A: Plasma earnitine deficiency. Ant J Dis Child 141:660-665, 1987
25. HOPPEL CL: Carnitine and earniline palmitoyltransterase in fatty acid oxidation and ketosis. Fed Pnn 41:2853-2857, 1982
26. BRECHER P: The interaction of long chain acyl-CoA with membranes. Mol Cell Biochem 237:3-15, 1983
27. SHUG AL, SHRAGO E, BIITAR N, FOLTS JD, KOKE JR: Acyl-CoA inhibition of adenine nucleotide translocation in ischemic myocardium. Am J Physiol 228:689-692, 1975
28. BERGSTÖM J. ASABA H. FÜRST P. LINDHOLM B: Middle molecules in chronic uremic patients treated wilh peritoneal dialysis, in Advances in Peritoneal Dialysis, edited by GAHI, GM, KESSEL M, NOLPH KD, Amsterdam. Excerpta Medica, 1981, pp 47-53